These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 37290473)

  • 1. Opportunities and challenges of leveraging COVID-19 vaccine innovation and technologies for developing sustainable vaccine manufacturing capabilities in Africa.
    Kana BD; Arbuthnot P; Botwe BK; Choonara YE; Hassan F; Louzir H; Matsoso P; Moore PL; Muhairwe A; Naidoo K; Ndomondo-Sigonda M; Madhi SA
    Lancet Infect Dis; 2023 Aug; 23(8):e288-e300. PubMed ID: 37290473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccines: New challenges, new paradigms, new opportunities: Report of the 22nd DCVMN Annual General Meeting.
    Kumar Suri R; Hayman B; Prasad SD; Makhoana M; Tippoo P
    Vaccine; 2022 Jun; 40(26):3495-3505. PubMed ID: 35577632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Future of Epidemic and Pandemic Vaccines to Serve Global Public Health Needs.
    Farlow A; Torreele E; Gray G; Ruxrungtham K; Rees H; Prasad S; Gomez C; Sall A; Magalhães J; Olliaro P; Terblanche P
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 preparedness: capacity to manufacture vaccines, therapeutics and diagnostics in sub-Saharan Africa.
    Bright B; Babalola CP; Sam-Agudu NA; Onyeaghala AA; Olatunji A; Aduh U; Sobande PO; Crowell TA; Tebeje YK; Phillip S; Ndembi N; Folayan MO
    Global Health; 2021 Mar; 17(1):24. PubMed ID: 33658050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global pandemic preparedness: learning from the COVID-19 vaccine development and distribution.
    Agampodi S; Mogeni OD; Chandler R; Pansuriya M; Kim JH; Excler JL
    Expert Rev Vaccines; 2024; 23(1):761-772. PubMed ID: 39167221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Building global vaccine manufacturing capacity: Spotlight on Africa.
    Rubin Thompson LJ; Grubo M; Veller M; Badenhorst RH; Nott J; Debruyne L; Makadzange T; Nicolaou S; Stanberry L; Sall A; James WG
    Vaccine; 2023 Jun; 41(27):4050-4056. PubMed ID: 37173266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors, enablers and challenges for COVID-19 vaccine development.
    Excler JL; Saville M; Privor-Dumm L; Gilbert S; Hotez PJ; Thompson D; Abdool-Karim S; Kim JH
    BMJ Glob Health; 2023 Jun; 8(6):. PubMed ID: 37277195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 vaccinology landscape in Africa.
    Baptista S; Naidoo S; Suliman S; Nepolo E; Kanoi BN; Gitaka J; Blessing OM; Enany S
    Front Immunol; 2022; 13():955168. PubMed ID: 36544758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustainable vaccine manufacturing in low- and middle-Income countries.
    Hayman B; Kumar Suri R; Downham M
    Vaccine; 2022 Nov; 40(50):7288-7304. PubMed ID: 36334966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 as a catalyst for vaccine manufacturing: A South African experience.
    Moore PL; Gray G
    Cell Host Microbe; 2023 Jun; 31(6):839-842. PubMed ID: 37321166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pandemic preparedness and response: beyond the Access to COVID-19 Tools Accelerator.
    Saxena A; Baker BK; Banda A; Herlitz A; Miller J; Karrar K; Fleurbaey M; Chiwa E; Atuire CA; Hirose I; Hassoun N
    BMJ Glob Health; 2023 Jan; 8(1):. PubMed ID: 36650015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strengthening vaccines and medicines manufacturing capabilities in Africa: challenges and perspectives.
    Saied AA; Metwally AA; Dhawan M; Choudhary OP; Aiash H
    EMBO Mol Med; 2022 Aug; 14(8):e16287. PubMed ID: 35758210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The COVID-19 experience in Africa and the Middle East.
    Bizri AR; Al Akoury N; Mhlanga T; Morales GDC; Haridy H; Hussey GD; Srivastava A
    Ann Med; 2023 Dec; 55(1):2222641. PubMed ID: 37345635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring future perspectives and pipeline progression in vaccine research and development.
    Vecchio R; Gentile L; Tafuri S; Costantino C; Odone A
    Ann Ig; 2024; 36(4):446-461. PubMed ID: 38436081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advancing development of medical countermeasures: Incorporating COVID-19 lessons learned into future pandemic preparedness planning.
    Johnson RA; White RC; Disbrow GL
    Hum Vaccin Immunother; 2022 Nov; 18(6):2129930. PubMed ID: 36302122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving pandemic preparedness through better, faster influenza vaccines.
    Newland M; Durham D; Asher J; Treanor JJ; Seals J; Donis RO; Johnson RA
    Expert Rev Vaccines; 2021 Mar; 20(3):235-242. PubMed ID: 33576708
    [No Abstract]   [Full Text] [Related]  

  • 17. Developing-country vaccine manufacturers' technical capabilities can make a difference in global immunization.
    Hayman B; Dennehy M
    Vaccine; 2021 Aug; 39(36):5153-5161. PubMed ID: 34362602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Global Intellectual Property Waiver is Still Needed to Address the Inequities of COVID-19 and Future Pandemic Preparedness.
    Amin T; Kesselheim AS
    Inquiry; 2022; 59():469580221124821. PubMed ID: 36124939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The need for Africa to develop capacity for vaccinology as a means of curbing antimicrobial resistance.
    Akegbe H; Onyeaka H; Michael Mazi I; Alex Olowolafe O; Dolapo Omotosho A; Olatunji Oladunjoye I; Amuda Tajudeen Y; Seun Ofeh A
    Vaccine X; 2023 Aug; 14():100320. PubMed ID: 37293248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equal access of COVID-19 vaccine distribution in Africa: Challenges and way forward.
    Aborode AT; Olofinsao OA; Osmond E; Batubo AP; Fayemiro O; Sherifdeen O; Muraina L; Obadawo BS; Ahmad S; Fajemisin EA
    J Med Virol; 2021 Sep; 93(9):5212-5215. PubMed ID: 34009657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.